2025 HCPCS Code C9093
Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
TAGS: implant sustained intravitreal release| Notice | HCPCS C9093 terminated on June 30, 2022. |
| Short Description | Inj., susvimo, 0.1 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | April 01, 2022 |
| HCPCS Action Effective Date | July 01, 2022 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Type Of Service Code | 9 - Other medical items or services |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9248 - Inj, clevidipine butyrate
- C9250 - Artiss fibrin sealant
- C9254 - Injection, lacosamide
- C9257 - Bevacizumab injection
- C9275 - Hexaminolevulinate hcl
- C9285 - Patch, lidocaine/tetracaine
- C9290 - Inj, bupivacaine liposome
- C9293 - Injection, glucarpidase
- C9349 - Puraply, puraply antimic
- C9352 - Neuragen nerve guide, per cm
- C9353 - Neurawrap nerve protector,cm
- C9354 - Veritas collagen matrix, cm2
- C9355 - Neuromatrix nerve cuff, cm
- C9356 - Tenoglide tendon prot, cm2
- C9358 - Surgimend, fetal
- C9359 - Implnt,bon void filler-putty
- C9360 - Surgimend, neonatal
- C9361 - Neuromend nerve wrap
- C9362 - Implnt,bon void filler-strip
- C9363 - Integra meshed bil wound mat